Bioengineered.2022 Jan;13(1):774-788.doi: 10.1080/21655979.2021.2012919.
2022-03-04Bioengineered.2022 Jan;13(1):774-788.doi: 10.1080/21655979.2021.2012919.in type I diabetes through triggering mitochondrial injury.
Bioengineered.2022 Jan;13(1):774-788.doi: 10.1080/21655979.2021.2012919.in type I diabetes through triggering mitochondrial injury.
Exp Ther Med. 2022 Feb;23(2):172. doi: 10.3892/etm.2021.11095. Epub 2021 Dec 27. Effect of Src tyrosine kinase on a rat model of asthma
Neural Regen Res.2022 Aug;17(8):1795-1801.doi: 10.4103/1673-5374.332157.Oxidized low-density lipoprotein receptor 1: a novel potential therapeutic target for intracerebral hemorrhage.
J Biol Chem.2022 Jan 5;298(2):101561.doi:10.1016/j.jbc.2022.101561.Inhibition of high-fat diet-induced obesity via reduction of ER-resident protein Nogo occurs through multiple mechanisms.
Mol Ther.2022 Jan 22;S1525-0016(22)00033-8.doi: 10.1016/j.ymthe.2022.01.033.A microRNA checkpoint for Ca 2+ signaling and overload in acute pancreatitis.
Bioengineered. 2022 Feb;13(2):3969-3980. doi: 10.1080/21655979.2022.2031401. Knockdown of long noncoding RNA metastasis-associated lung adenocarcinoma transcript 1 protects against intracerebral hemorrhage through microRNA-146a-mediated inhibition of inflammation and oxidative stress
EMBO Rep . 2022 Feb 3;23(3):e50851. doi: 10.15252/embr.202050851. Epub 2022 Jan 5. Piwi/piRNAs control food intake by promoting neuropeptide F expression in locusts
Prostate. 2022 Jan;82(1):26-40. doi: 10.1002/pros.24245. Epub 2021 Sep 30. Regulatory mechanism of androgen receptor on NCAPD3 gene expression in prostate cancer
Osteoarthritis Cartilage 2022 Apr;30(4):613-625. doi: 10.1016/j.joca.2022.01.002. Epub 2022 Jan 7. N(6)-methyladenosine RNA methyltransferase like 3 inhibits extracellular matrix synthesis of endplate chondrocytes by downregulating sex-determining region Y-Box transcription factor 9 expression under tension.
J Thromb Thrombolysis. 2022 Jan;53(1):136-148. doi: 10.1007/s11239-021-02540-1. Epub 2021 Aug 5. Overexpression of miR-1298 attenuates myocardial ischemia-reperfusion injury by targeting PP2A